NEW HOPE, PA — Orchestra BioMed Holdings Inc. (Nasdaq: OBIO) will present its biomedical development strategy to investors at the Wells Fargo 21st Annual Healthcare Conference on Sept. 10 as …
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.